After the third treatment cycle, beacizumab was associated with significantly more toxic eents, particularly febrile neutropenia and pulmonary hemorrhage.

• 在第三个治疗周期后，贝伐单抗与显著增多的毒性事件有关系，特别是发热引起的粒细胞减少和肺出血。